U.S. markets open in 6 hours 27 minutes
  • S&P Futures

    4,206.75
    -16.25 (-0.38%)
     
  • Dow Futures

    33,872.00
    -145.00 (-0.43%)
     
  • Nasdaq Futures

    13,909.25
    -72.00 (-0.51%)
     
  • Russell 2000 Futures

    2,297.90
    -12.20 (-0.53%)
     
  • Crude Oil

    71.79
    -0.36 (-0.50%)
     
  • Gold

    1,815.40
    -46.00 (-2.47%)
     
  • Silver

    27.07
    -0.75 (-2.69%)
     
  • EUR/USD

    1.1988
    -0.0145 (-1.20%)
     
  • 10-Yr Bond

    1.5690
    0.0000 (0.00%)
     
  • Vix

    18.15
    +1.13 (+6.64%)
     
  • GBP/USD

    1.3996
    -0.0087 (-0.61%)
     
  • USD/JPY

    110.6400
    +0.6060 (+0.55%)
     
  • BTC-USD

    39,188.50
    -1,272.67 (-3.15%)
     
  • CMC Crypto 200

    974.21
    -18.26 (-1.84%)
     
  • FTSE 100

    7,184.95
    0.00 (0.00%)
     
  • Nikkei 225

    29,018.33
    -272.68 (-0.93%)
     

Biogen posts 18.7 pct jump in quarterly profit

Oct 24 (Reuters) - U.S. drugmaker Biogen Inc on Tuesday reported an 18.7 percent rise in quarterly profit, driven by strong demand for its recently approved spinal muscular atrophy drug, Spinraza.

Total revenue rose to $3.08 billion from $2.96 billion.

Net income attributable to Biogen rose to $1.23 billion, or $5.79 per share, in the third quarter ended Sept. 30, compared with $1.03 billion, or $4.71 per share, a year earlier. (Reporting by Akankshita Mukhopadhyay and Manas Mishra in Bengaluru; Editing by Martina D'Couto)